等待开盘 07-07 09:30:00 美东时间
+0.294
+0.31%
After the fracture: how Britain's financial industry recovered from Brexit London's finance sector lost global market share and jobs post-Brexit, data shows Rising interest rates and deregulation have boosted bank and insurance profits European Union has failed to capitalise, Britain still competiti
06-21 16:00
BRIEF-DKSH Enters Strategic Distribution Partnership With Bridgebio June 11 (Reuters) - DKSH Holding AG DKSH.S : DKSH ENTERS STRATEGIC DISTRIBUTION PARTNERSHIP WITH BRIDGEBIO BBIO.O TO SUPPORT REGULATORY EVALUATION AND POTENTIAL PATIENT ACCESS TO TRANSTHYRETIN STABILIZER FOR ATTR-CM IN SELECTED ASIA
06-11 13:04
Mark Carney's trade push collides with reality of US dependence Canada's access to USMCA remains main attraction in its bid to woo foreign investors Japanese, Swedish, South Korean carmakers lobby to maintain access to US markets through Canada Canada is focused on Pacific trade deals, but Asian lea
06-09 13:00
BRIEF-Fuji Media’s Real Estate Unit Sankei Building Co Attracts 1 Trillion Yen Bids - Bloomberg News June 4 (Reuters) - FUJI MEDIA’S REAL ESTATE UNIT SANKEI BUILDING CO ATTRACTS 1 TRILLION YEN BIDS - BLOOMBERG NEWS Source text: https://bit.ly/4fJePVp Further company coverage: 4676.T (( Reuters.Brief
06-04 16:54
UPDATE 1-CANAL+ becomes first French company to list in Johannesburg CANAL+ aims to broaden shareholder base, boost liquidity via JSE listing Broadcaster secures new sports rights deals via SuperSport JSE chairman says listing shows global confidence in South Africa's markets Recasts with CEO's comm
06-03 22:23
BridgeBio publishes corporate presentation outlining rare-disease pipeline and 2026 milestones BridgeBio highlighted Attruby (acoramidis) as approved for ATTR-CM, citing Q1 2026 net product revenue of USD 180.6 million. Presentation cited a 42% reduction in all-cause mortality and cardiovascular hos
06-03 17:06
Shares of BridgeBio Pharma (BBIO) slipped in the premarket on Tuesday after Raymond James downgraded the stock, citing the impact from the loss of exclusivity for Pfizer’s (PFE) heart drug Vyndamax, w...
05-26 21:25
BRIEF-Miniso Group Posts Qtrly Profit Attributable Of RMB1.25 Billion May 26 (Reuters) - MINISO Group Holding Ltd 9896.HK : MINISO GROUP ANNOUNCES MARCH QUARTER 2026 UNAUDITED FINANCIAL RESULTS QTRLY REVENUE RMB5,688.4 MILLION QTRLY PROFIT ATTRIBUTABLE RMB1.25 BILLION Further company coverage: 9896.
05-26 16:39
BRIEF-Ebay Rejects Unsolicited Proposal From Gamestop eBay Inc EBAY.O : EBAY REJECTS UNSOLICITED PROPOSAL FROM GAMESTOP EBAY: CONCLUDED THAT GAMESTOP PROPOSAL IS NEITHER "CREDIBLE NOR ATTRACTIVE" EBAY: BOARD IS CONFIDENT THAT CO, UNDER ITS CURRENT MANAGEMENT TEAM, IS WELL-POSITIONED TO CONTINUE TO
05-12 18:01
Alnylam says HELIOS-B analysis shows vutrisiran benefit across ATTR-CM patient groups Alnylam highlighted new analyses from HELIOS-B Phase 3 trial of vutrisiran in ATTR-CM, with results already presented at Heart Failure 2026. Analyses showed clinical benefit remained consistent across harder-to-tre
05-12 14:30